Abstract
C23H25BrO6, triclinic, P
The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Data collection and handling.
| Crystal: | Colorless block |
| Size: | 0.16 × 0.12 × 0.09 mm |
| Wavelength: | Cu Kα radiation (1.54184 Å) |
| μ: | 2.90 mm−1 |
| Diffractometer, scan mode: | XtaLAB Synergy, ω |
| θmax, completeness: | 77.4°, >99 % |
| N(hkl)measured, N(hkl)unique, Rint: | 14,127, 4301, 0.068 |
| Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 3720 |
| N(param)refined: | 275 |
| Programs: | CrysAlisPRO [1], Olex2 [2], SHELX [3] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
| Atom | x | y | z | Uiso*/Ueq |
|---|---|---|---|---|
| Br1 | 1.27441 (4) | 1.03425 (4) | 0.27130 (2) | 0.07969 (18) |
| O1 | −0.5527 (2) | 0.2611 (2) | 0.92297 (10) | 0.0592 (4) |
| O2 | −0.3932 (2) | 0.1774 (2) | 1.05043 (9) | 0.0608 (4) |
| O3 | −0.0506 (2) | 0.2060 (3) | 1.05879 (10) | 0.0647 (5) |
| O4 | −0.0102 (2) | 0.4337 (2) | 0.80501 (8) | 0.0519 (4) |
| O5 | −0.4464 (2) | 0.4387 (3) | 0.75866 (12) | 0.0702 (5) |
| O6 | 0.5160 (3) | 0.7301 (3) | 0.52979 (10) | 0.0689 (5) |
| C1 | −0.0968 (3) | 0.3652 (3) | 0.86886 (12) | 0.0474 (5) |
| C2 | −0.2751 (3) | 0.3481 (3) | 0.86180 (12) | 0.0471 (5) |
| C3 | −0.3779 (3) | 0.2831 (3) | 0.92368 (13) | 0.0483 (5) |
| C4 | −0.2960 (3) | 0.2429 (3) | 0.98960 (13) | 0.0509 (5) |
| C5 | −0.1142 (3) | 0.2589 (3) | 0.99307 (13) | 0.0507 (5) |
| C6 | −0.0102 (3) | 0.3218 (3) | 0.93210 (12) | 0.0507 (5) |
| H6 | 0.112223 | 0.333828 | 0.934228 | 0.061* |
| C7 | −0.3098 (3) | 0.4184 (3) | 0.78802 (13) | 0.0520 (5) |
| C8 | −0.1365 (3) | 0.4690 (3) | 0.75421 (13) | 0.0496 (5) |
| C9 | −0.1045 (3) | 0.5373 (3) | 0.68580 (13) | 0.0511 (5) |
| H9 | −0.204283 | 0.554741 | 0.657994 | 0.061* |
| C10 | 0.0579 (3) | 0.5897 (3) | 0.64666 (12) | 0.0469 (5) |
| C11 | 0.2201 (3) | 0.5822 (3) | 0.67850 (12) | 0.0512 (5) |
| H11 | 0.227786 | 0.542114 | 0.728913 | 0.061* |
| C12 | 0.3686 (3) | 0.6319 (3) | 0.63819 (13) | 0.0544 (5) |
| H12 | 0.477619 | 0.627938 | 0.661358 | 0.065* |
| C13 | 0.3612 (3) | 0.6881 (3) | 0.56357 (13) | 0.0518 (5) |
| C14 | 0.2019 (3) | 0.6975 (3) | 0.53078 (13) | 0.0556 (5) |
| H14 | 0.194836 | 0.736961 | 0.480220 | 0.067* |
| C15 | 0.0530 (3) | 0.6488 (3) | 0.57237 (13) | 0.0539 (5) |
| H15 | −0.055761 | 0.655973 | 0.549613 | 0.065* |
| C16 | 0.5260 (4) | 0.7836 (4) | 0.45233 (14) | 0.0607 (6) |
| H16A | 0.474245 | 0.888259 | 0.445468 | 0.073* |
| H16B | 0.465214 | 0.692991 | 0.418677 | 0.073* |
| C17 | 0.7162 (4) | 0.8174 (3) | 0.43548 (14) | 0.0601 (6) |
| H17A | 0.763082 | 0.709899 | 0.442426 | 0.072* |
| H17B | 0.774063 | 0.900676 | 0.473109 | 0.072* |
| C18 | 0.7629 (4) | 0.8852 (3) | 0.35637 (14) | 0.0601 (6) |
| H18A | 0.718303 | 0.993521 | 0.348261 | 0.072* |
| H18B | 0.710146 | 0.801822 | 0.317695 | 0.072* |
| C19 | 0.9600 (4) | 0.9151 (4) | 0.34884 (15) | 0.0630 (6) |
| H19A | 1.011316 | 0.993899 | 0.389522 | 0.076* |
| H19B | 1.002512 | 0.805413 | 0.355846 | 0.076* |
| C20 | 1.0191 (4) | 0.9887 (4) | 0.27333 (16) | 0.0656 (6) |
| H20A | 0.973057 | 1.096085 | 0.264740 | 0.079* |
| H20B | 0.974839 | 0.907453 | 0.232375 | 0.079* |
| C21 | −0.6376 (3) | 0.1674 (4) | 0.85969 (15) | 0.0622 (6) |
| H21A | −0.680648 | 0.246570 | 0.824588 | 0.093* |
| H21B | −0.734585 | 0.084337 | 0.877951 | 0.093* |
| H21C | −0.555395 | 0.107424 | 0.833404 | 0.093* |
| C22 | −0.4035 (5) | 0.2988 (4) | 1.10891 (17) | 0.0761 (8) |
| H22A | −0.458260 | 0.392111 | 1.088902 | 0.114* |
| H22B | −0.287062 | 0.344351 | 1.127402 | 0.114* |
| H22C | −0.472487 | 0.243507 | 1.150747 | 0.114* |
| C23 | 0.1317 (4) | 0.2066 (4) | 1.06402 (16) | 0.0705 (7) |
| H23A | 0.166512 | 0.132123 | 1.024634 | 0.106* |
| H23B | 0.160335 | 0.165076 | 1.114055 | 0.106* |
| H23C | 0.192991 | 0.323097 | 1.056965 | 0.106* |
1 Source of material
The 2-(4-hydroxyphenyl)-5,6,7-trimethoxy-4H-chromen-4-one (0.16 g, 0.5 mmol) and 1,5-dibromopentane (0.09 mL, 0.75 mmol) were dissolved in 10 mL of acetone, and potassium carbonate (0.14 g, 1 mmol) and catalyzed potassium (0.017 g, 0.1 mmol) iodide were added to the mixed solution for reflux reaction at 333 K for about 9 h. After the reaction was completed, the solvent was evaporated under vacuum. The residue was subjected to flash column chromatography on silicagel (petroleum ether/ethyl acetate = 5:1), and recrystallized with methanol to obtain yellow powder target compound.
2 Experimental details
The carbon-bound hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on their parent atoms.
3 Comment
Aurones, which are flavonoids, possess an unusual 5-membered C-ring biosynthesized from chalcones by mainly performing B ring oxidation [4]. Aurones and their derivatives are the basic structures of many natural plant and bioactive compounds and play an important role in medicinal chemistry [5], [6], [7], [8].
The basic structure of the title compound is aurone, containing an aurone core, a bromo-pentyl group. The key lengths and angles obtained from the title structure are within the normal range and are consistent with those previously reported in similar structures [9], [10], [11].The distance of C8=C9 double bond is 1.329(4) Å and the double bond adopts a Z-configuration, which was defined by the dihedral angle of 0.6(4)∘ for O4–C8–C9–C10. The keto group was confirmed by the distance of 1.220(3) Å (C7–O5). The three methoxy groups on the benzene ring, the angles with the ring are 51.3(3)∘ (C2–C3–O1–C21), 81.5(3)∘ (C4–C5–O2–C22), and 175.4(2)∘ (C4–C5–O3–C23), respectively.
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: The authors gratefully acknowledge support from the project of Guizhou Administration of Traditional Chinese Medicine, research on science and Technology of traditional Chinese medicine and ethnic medicine of Guizhou Provincial Administration of Traditional Chinese Medicine. (No. QZYY-2021-008), the Guizhou Provincial Basic Research Program (Natural Science) (Qian Ke He Ji Chu- ZK[2023] Zhong Dian 047), the Research innovation and exploration program of Guizhou University of Traditional Chinese Medicine (2018YFC170810203).
References
1. CrysAlisPRO Software; Rigaku Oxford Diffraction [CP/DK]: Japan, 2015.Suche in Google Scholar
2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar
3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar
4. Yatabe, T., Jin, X. J., Mizuno, N., Yamaguchi, K. Unusual olefinic C–H functionalization of simple chalcones toward aurones enabled by the rational design of a function-integrated heterogeneous catalyst. ACS Catal. 2018, 8, 4969–4978; https://doi.org/10.1021/acscatal.8b00727.Suche in Google Scholar
5. Abou Baker, D. H. An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: a comprehensive review based on up to date knowledge. Toxicol. Rep. 2022, 9, 445–469; https://doi.org/10.1016/j.toxrep.2022.03.011.Suche in Google Scholar PubMed PubMed Central
6. Wang, K. N., Ma, S. Y., Ma, Y. Y., Zhao, Y. P., Xing, M. M., Zhou, L. Y., Cao, D. X., Lin, W. Y. Aurone derivative revealing the metabolism of lipid droplets and monitoring oxidative stress in living cells. Anal. Chem. 2020, 92, 6631–6636; https://doi.org/10.1021/acs.analchem.0c00456.Suche in Google Scholar PubMed
7. Aleffi, G. S., Rosa, A. S., de Souza, L. G., Avelar, J. L. S., Nascimento, S. M. R., de Almeida, V. M., Tucci, A. R., Ferreira, V. N., da Silva, A. J. M., SantosFilho, O. A., Miranda, M. D., CostaAurones, P. R. R. A promising scaffold to inhibit SARS–CoV-2 replication. J. Nat. Prod. 2023, 86, 1536–1549; https://doi.org/10.1021/acs.jnatprod.3c00249.Suche in Google Scholar PubMed
8. Hirazawa, S., Saito, Y., Sagano, M., Goto, M., Nakagawa–Goto, K. Chemical space expansion of flavonoids: induction of mitotic inhibition by replacing ring B with a 10π-electron system, benzo[b]thiophene. J. Nat. Prod. 2022, 85, 136–147; https://doi.org/10.1021/acs.jnatprod.1c00867.Suche in Google Scholar PubMed
9. Shin, S. Y., Ahn, S., Koh, D. The crystal structure of (Z)-2-(2,3-dimethoxybenzylidene)naphtho-[1,2-b]furan-3(2H)-one, C21H16O4. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 1189–1191; https://doi.org/10.1515/ncrs-2022–0454.10.1515/ncrs-2022-0454Suche in Google Scholar
10. Zheng, L. L., Liu, X. L., Dong, Z. C., Shi, Y., Pan, B. W., Feng, T. T. Crystal structure of (E)-3-(3-methoxybenzylidene) benzofuran-2(3H)-one, C16H12O3. Z. Kristallogr. N. Cryst. Struct. 2023, 238, 729–731; https://doi.org/10.1515/ncrs-2023–0176.10.1515/ncrs-2023-0176Suche in Google Scholar
11. Euler, H., Kirfel, A., Freudenthal, S., Müller, C. Crystal structure of 8-(5-bromopentyl)-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene, C18H24BBrF2N2. Z. Kristallogr. N. Cryst. Struct. 2002, 217, 543–545; https://doi.org/10.1524/ncrs.2002.217.jg.543.Suche in Google Scholar
© 2023 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of (N-([1,1′:4′,1″-terphenyl]-4,4′-diethyl)-2-(bis(pyridin-2-ylmethyl)amino)acetamide-κ4N,N,N″, O)tri(nitrato-kO, O′) samarium(III) - methanol - acetonitrile (1/1/1), C40H39SmN8O14
- The crystal structure of 6,6′-(((2-(dimethylamino)ethyl)azanediyl)bis(methylene))bis(2-chloro-4-methyl phenolate-κ4N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)-titanium(IV), C27H27Cl2N3O6Ti
- N′-[(1E)-(4–Fluorophenyl)methylidene]adamantane-1-carbohydrazide, C18H21FN2O
- Crystal structure of 4-bromo-3-nitro-1H-pyrazole-5-carboxylic acid monohydrate, C4H2N3BrO4·H2O
- Crystal structure of dipyridine-k1N-tris(2,2,6,6-tetramethyl-5-oxohept-3-en-3-olato-k2O,O′)dysprosium(III), DyC43H67O6N2
- Crystal structure of cyclo[tetraiodido-bis{μ2-1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-isopropyl-imidazol)-k2N:N}dicadmiun(II)], C26H30N10Cd2I4
- The crystal structure of tert-butyl (E)-3-(2-(benzylideneamino)phenyl)-1H-indole-1-carboxylate, C26H24N2O2
- The crystal structure of 4-(3-carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4- dihydroquinolin-7-yl)-2-methylpiperazin-1-ium 2,5-dihydroxybenzoate methanol solvate, C27H32FN3O9
- Crystal structure of (μ2-1-(4,4′-bipyridine-κ2N:N′)-bis[diaqua-(4-iodopyridine-2,6-dicarboxylato-κ3O,N,O′)–cobalt(II)], C24H20Co2I2N4O12
- The crystal structure of dimethyl 4,4′-(10,20-diphenylporphyrin-5,15-diyl)dibenzoate dichloromethane solvate, C49H36N4O4Cl2
- (E)-2-((E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-ylidene)hydrazine-1-carbothioamide C14H23N3S1
- The crystal structure of [1-(4-(trifluoromethyl)phenyl)-3,4-dihydroquinolin-2(1H)-one], C16H12F3NO
- Crystal structure of (E)-2-amino-N′-((3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl)methylene)benzohydrazide – dimethylformamide – water (1/1/2), C15H16N4O3·C3H7NO·2H2O
- Crystal structure of 3-(4-bromophenyl)-5-methyl-1H-pyrazole, C10H9BrN2
- Crystal structure of 1,10-phenanthrolinium bromide dihydrate, C12H9N2Br
- Crystal structure of N-(4′-chloro-[1,1′-biphenyl]-2-yl)formamide, C13H10ClNO
- The crystal structure of nitroterephthalic acid, C8H5NO6
- Crystal structure of (2-((4-bromo-2,6-dichlorophenyl)amino)phenyl) (morpholino)methanone, C17H15BrCl2N2O2
- Crystal structure of tetraaqua-bis(ethanol-κO)-tetrakis(μ2-trifluoroacetate-κ2O:O′)-bis(trifluoroacetate-κ2O)digadolinium(III) Gd2C16H20O18F18
- The crystal structure of dimethyl 4,4′-[10,20-bis(2,6-difluorophenyl)porphyrin-5,15-diyl]dibenzoate chloroform solvate, C50H32Cl6F4N4O4
- The crystal structure of N,N′-((nitroazanediyl)bis(methylene))diacetamide, C6H12O4N4
- The crystal structure of [bis(2,2′-bipyridine-6-carboxylato-κ3N,N,O)magnesium(II)]dihydrate, C22H18N4O6Mg
- Crystal structure of poly[diaqua-(bis(μ2-1,4-bis(imidazol-1-ylmethyl)benzene)-κ2N,N′] cobalt(II)-tetraqua-bis(1,4-bis(imidazol-1-ylmethyl)benzene)-κ1N)-cobalt(II) di(2,5-thiophenedicarboxylate) dihydrate, C68H76Co2N16O16S2
- Crystal structure of poly[chlorido-μ2-chlorido-(μ2-1-[(2-ethyl-4-methyl-1H-imidazol-1-yl)methyl]-1H-benzotriazole-κN:N’)cadmium(II)], C13H15CdN5Cl2
- The crystal structure of (4-hydroxybenzenesulfonate)-k1O-6,6′-((1E,1′E)- (ethane-1,2-diylbis(azaneylylidene))bis(methaneylylidene)) bis(2-methoxyphenol)-κ2N,N,μ2O,O,κ2O, O)-(methanol)-cobalt(II) sodium(I), C25H27CoN2NaO9S
- Crystal structure of (1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)(4-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)amino)piperidin-1-yl)methanone, C17H18F6N6O
- Crystal structure of bis{[(cyclohexylimino)(phenylimino)-l5-(methyl)diethylazane-κ2N:N′]-(ethyl)-zinc(II)]}, C38H62N6Zn2
- Crystal structure of 2-[(4-bromobenzyl)thio]-5-(5-bromothiophen-2-yl)-1,3,4-oxadiazole, C13H8Br2N2OS2
- Crystal structure of 10-methoxy-7,11b,12,13-tetrahydro-6H-pyrazino [2′,3′:5,6]pyrazino[2,1-a]isoquinoline, C15H16N4O
- The crystal structure of 1-propyl-2-nitro-imidazole oxide, C6H9N3O3
- The crystal structure of 3-nitrobenzene-1,2-dicarboxylic acid–2-ethoxybenzamide (1/1), C17H16N2O8
- The structure of RUB-1, (C8H16N)6[B6Si48O108], a boron containing levyne-type zeolite, occluding N-methyl-quinuclidinium in the cage-like pores
- The crystal structure of diaqua-(naphthalene-4,5-dicarboxylate-1,8-dicarboxylic anhydride-κ1O)-(4′-(4-(1H-benzimidazolyl-1-yl)phenyl)-2,2′:6′,2″-terpyridine-κ3N,N′,N″)–manganese(II) dihydrate, C42H27MnN5O9·2H2O
- Crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene))bis (3-(3-bromopropoxy)phenol), C20H22Br2N2O4
- The crystal structure of 3-(2-hydroxyphenyl)-4-phenyl-6-(p-tolyl)-2H-pyran-2-one, C24H18O3
- Crystal structure of bis(μ2-2-(1,5-dimethyl–3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino)methyl)phenolato-κ4O:O,N,O′)-(nitrato-κ2O,O′)dicobalt(II), C36H32Co2N8O4
- Synthesis and crystal structure of (3E,5S,10S,13S,14S,17Z)-17-ethylidene-10,13-dimethylhexadecahydro-3H-cyclopenta[α] phenanthren-3-one O-(4-fluorobenzoyl) oxime, C28H36FNO2
- The crystal structure of 4-aminiumbiphenyl benzenesulfonate, C18H17NO3S
- Synthesis and crystal structure of 1-(7-hydroxy-3-(4-hydroxy-3-nitrophenyl)-4-oxo-4H-chromen-8-yl)-N,N-dimethylmethanaminiumnitrate, C18H17N3O9
- Crystal structure of N-(Ar)-N′-(Ar′)-formamidine, C14H12Br2N2O
- The crystal structure of 4-(2,4-dichlorophenyl)-2-(4-fluorophenyl)-5-methyl-1H-imidazole, C16H11Cl2FN2
- Crystal structure of 1-(4–chlorophenyl)-4-benzoyl-3-methyl-1H-pyrazol-5-ol, C17H13ClN2O2
- The crystal structure of 5-amino-1-methyl-4-nitroimidazole, C4H6O2N4
- Crystal structure of 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene-N,N′-bis(1,3-bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-1,3,2-diazaborol-2-yl)-l2-germenediamine, C63H94B2GeN8
- The crystal structure of (bromido, chlorido)-tricarbonyl-(5,5′-dimethyl-2,2′-bipyridine)-rhenium(I), C15H12Br0.2Cl0.8N2O3Re1
- Crystal structure of [N(E),N′(E)]-N,N′-(1,4-phenylenedimethylidyne)bis-3,5-bis(propan-2-yl)-1H-pyrazol-4-amine, C26H36N6
- The crystal structure of poly[2-(4-carboxypyridin-3-yl)terephthalpoly[diaqua-(μ4-2-(6-carboxylatopyridin-3-yl)terephthalato-κ5O,N:O′:O″,O‴)]) cadmium(II)] dihydrate, C28H20Cd3N2O16
- Crystal structure of [tetraaqua-bis((3-carboxy-5-(pyridin-4-yl)benzoate-κ1N)cobalt(II)] tetrahydrate, C26H32CoN2O16
- Crystal structure of bis(μ2-azido-κ2N:N)-tetrakis(azido-κ1N)-tetrakis(1,10-phenanthroline-κ2N,N′)dibismuth(III), C48H32N26Bi2
- Crystal structure of (Z)-N-(4-(4-(4-((4,5,6-trimethoxy-3-oxobenzofuran-2(3H)-ylidene)methyl)phenoxy)butoxy)phenyl)acetamide, C30H31NO8
- Crystal structure of poly[diaqua-(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)-bis(μ2-5-carboxybenzene-1,3-dicarboxylato-O,O′:O″)-aqua-di-zinc dihydrate solvate], C27H28N4O16Zn2
- Crystal structure of 2-(3,5,5-trimethylcyclohex-2-en-1-ylidene)malononitrile, C12H14N2
- Crystal structure of chlorido-(5-nitro-2-phenylpyridine-κ2N,C)-[(methylsulfinyl)methane-κ1S]platinum(II), C13H13ClN2O3PtS
- The crystal structure of the co-crystal 1,4-dioxane–4,6-bis(nitroimino)-1,3,5-triazinan-2-one(2/1), C11H19N7O9
- Crystal structure of [N(E),N′(E)]-N,N′-(1,4-phenylenedimethylidyne)bis-3,5-dimethyl-1H-pyrazol-4-amine di-methanol solvate, C18H20N6·2(CH3OH)
- Crystal structure of catena-poly[bis(μ2-azido-k2N:N′)-(nitrato-K2N:N′)-bis(1,10-phenanthroline-K2N:N′)samarium(III)], C24H16N11O3Sm
- Crystal structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2H)-one, C23H25BrO6
- Crystal structure of bis(3,5-dimethyl-1H-pyrazol-4-ammonium) tetrafluoroterephthate, 2[C5H10N3][C8F4O4]
- Crystal structure of 2-amino-4-(2-fluoro-4-(trifluoromethyl)phenyl)-9-methoxy-1,4,5,6-tetrahydrobenzo[h]quinazolin-3-ium chloride, C20H18ClF4N3O
- Crystal structure of 6-(pyridin-3-yl)-1,3,5-triazine-2,4-diamine-sebacic acid (2/1), C13H17N6O2
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of (N-([1,1′:4′,1″-terphenyl]-4,4′-diethyl)-2-(bis(pyridin-2-ylmethyl)amino)acetamide-κ4N,N,N″, O)tri(nitrato-kO, O′) samarium(III) - methanol - acetonitrile (1/1/1), C40H39SmN8O14
- The crystal structure of 6,6′-(((2-(dimethylamino)ethyl)azanediyl)bis(methylene))bis(2-chloro-4-methyl phenolate-κ4N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)-titanium(IV), C27H27Cl2N3O6Ti
- N′-[(1E)-(4–Fluorophenyl)methylidene]adamantane-1-carbohydrazide, C18H21FN2O
- Crystal structure of 4-bromo-3-nitro-1H-pyrazole-5-carboxylic acid monohydrate, C4H2N3BrO4·H2O
- Crystal structure of dipyridine-k1N-tris(2,2,6,6-tetramethyl-5-oxohept-3-en-3-olato-k2O,O′)dysprosium(III), DyC43H67O6N2
- Crystal structure of cyclo[tetraiodido-bis{μ2-1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-isopropyl-imidazol)-k2N:N}dicadmiun(II)], C26H30N10Cd2I4
- The crystal structure of tert-butyl (E)-3-(2-(benzylideneamino)phenyl)-1H-indole-1-carboxylate, C26H24N2O2
- The crystal structure of 4-(3-carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4- dihydroquinolin-7-yl)-2-methylpiperazin-1-ium 2,5-dihydroxybenzoate methanol solvate, C27H32FN3O9
- Crystal structure of (μ2-1-(4,4′-bipyridine-κ2N:N′)-bis[diaqua-(4-iodopyridine-2,6-dicarboxylato-κ3O,N,O′)–cobalt(II)], C24H20Co2I2N4O12
- The crystal structure of dimethyl 4,4′-(10,20-diphenylporphyrin-5,15-diyl)dibenzoate dichloromethane solvate, C49H36N4O4Cl2
- (E)-2-((E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-ylidene)hydrazine-1-carbothioamide C14H23N3S1
- The crystal structure of [1-(4-(trifluoromethyl)phenyl)-3,4-dihydroquinolin-2(1H)-one], C16H12F3NO
- Crystal structure of (E)-2-amino-N′-((3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl)methylene)benzohydrazide – dimethylformamide – water (1/1/2), C15H16N4O3·C3H7NO·2H2O
- Crystal structure of 3-(4-bromophenyl)-5-methyl-1H-pyrazole, C10H9BrN2
- Crystal structure of 1,10-phenanthrolinium bromide dihydrate, C12H9N2Br
- Crystal structure of N-(4′-chloro-[1,1′-biphenyl]-2-yl)formamide, C13H10ClNO
- The crystal structure of nitroterephthalic acid, C8H5NO6
- Crystal structure of (2-((4-bromo-2,6-dichlorophenyl)amino)phenyl) (morpholino)methanone, C17H15BrCl2N2O2
- Crystal structure of tetraaqua-bis(ethanol-κO)-tetrakis(μ2-trifluoroacetate-κ2O:O′)-bis(trifluoroacetate-κ2O)digadolinium(III) Gd2C16H20O18F18
- The crystal structure of dimethyl 4,4′-[10,20-bis(2,6-difluorophenyl)porphyrin-5,15-diyl]dibenzoate chloroform solvate, C50H32Cl6F4N4O4
- The crystal structure of N,N′-((nitroazanediyl)bis(methylene))diacetamide, C6H12O4N4
- The crystal structure of [bis(2,2′-bipyridine-6-carboxylato-κ3N,N,O)magnesium(II)]dihydrate, C22H18N4O6Mg
- Crystal structure of poly[diaqua-(bis(μ2-1,4-bis(imidazol-1-ylmethyl)benzene)-κ2N,N′] cobalt(II)-tetraqua-bis(1,4-bis(imidazol-1-ylmethyl)benzene)-κ1N)-cobalt(II) di(2,5-thiophenedicarboxylate) dihydrate, C68H76Co2N16O16S2
- Crystal structure of poly[chlorido-μ2-chlorido-(μ2-1-[(2-ethyl-4-methyl-1H-imidazol-1-yl)methyl]-1H-benzotriazole-κN:N’)cadmium(II)], C13H15CdN5Cl2
- The crystal structure of (4-hydroxybenzenesulfonate)-k1O-6,6′-((1E,1′E)- (ethane-1,2-diylbis(azaneylylidene))bis(methaneylylidene)) bis(2-methoxyphenol)-κ2N,N,μ2O,O,κ2O, O)-(methanol)-cobalt(II) sodium(I), C25H27CoN2NaO9S
- Crystal structure of (1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)(4-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)amino)piperidin-1-yl)methanone, C17H18F6N6O
- Crystal structure of bis{[(cyclohexylimino)(phenylimino)-l5-(methyl)diethylazane-κ2N:N′]-(ethyl)-zinc(II)]}, C38H62N6Zn2
- Crystal structure of 2-[(4-bromobenzyl)thio]-5-(5-bromothiophen-2-yl)-1,3,4-oxadiazole, C13H8Br2N2OS2
- Crystal structure of 10-methoxy-7,11b,12,13-tetrahydro-6H-pyrazino [2′,3′:5,6]pyrazino[2,1-a]isoquinoline, C15H16N4O
- The crystal structure of 1-propyl-2-nitro-imidazole oxide, C6H9N3O3
- The crystal structure of 3-nitrobenzene-1,2-dicarboxylic acid–2-ethoxybenzamide (1/1), C17H16N2O8
- The structure of RUB-1, (C8H16N)6[B6Si48O108], a boron containing levyne-type zeolite, occluding N-methyl-quinuclidinium in the cage-like pores
- The crystal structure of diaqua-(naphthalene-4,5-dicarboxylate-1,8-dicarboxylic anhydride-κ1O)-(4′-(4-(1H-benzimidazolyl-1-yl)phenyl)-2,2′:6′,2″-terpyridine-κ3N,N′,N″)–manganese(II) dihydrate, C42H27MnN5O9·2H2O
- Crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene))bis (3-(3-bromopropoxy)phenol), C20H22Br2N2O4
- The crystal structure of 3-(2-hydroxyphenyl)-4-phenyl-6-(p-tolyl)-2H-pyran-2-one, C24H18O3
- Crystal structure of bis(μ2-2-(1,5-dimethyl–3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino)methyl)phenolato-κ4O:O,N,O′)-(nitrato-κ2O,O′)dicobalt(II), C36H32Co2N8O4
- Synthesis and crystal structure of (3E,5S,10S,13S,14S,17Z)-17-ethylidene-10,13-dimethylhexadecahydro-3H-cyclopenta[α] phenanthren-3-one O-(4-fluorobenzoyl) oxime, C28H36FNO2
- The crystal structure of 4-aminiumbiphenyl benzenesulfonate, C18H17NO3S
- Synthesis and crystal structure of 1-(7-hydroxy-3-(4-hydroxy-3-nitrophenyl)-4-oxo-4H-chromen-8-yl)-N,N-dimethylmethanaminiumnitrate, C18H17N3O9
- Crystal structure of N-(Ar)-N′-(Ar′)-formamidine, C14H12Br2N2O
- The crystal structure of 4-(2,4-dichlorophenyl)-2-(4-fluorophenyl)-5-methyl-1H-imidazole, C16H11Cl2FN2
- Crystal structure of 1-(4–chlorophenyl)-4-benzoyl-3-methyl-1H-pyrazol-5-ol, C17H13ClN2O2
- The crystal structure of 5-amino-1-methyl-4-nitroimidazole, C4H6O2N4
- Crystal structure of 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene-N,N′-bis(1,3-bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-1,3,2-diazaborol-2-yl)-l2-germenediamine, C63H94B2GeN8
- The crystal structure of (bromido, chlorido)-tricarbonyl-(5,5′-dimethyl-2,2′-bipyridine)-rhenium(I), C15H12Br0.2Cl0.8N2O3Re1
- Crystal structure of [N(E),N′(E)]-N,N′-(1,4-phenylenedimethylidyne)bis-3,5-bis(propan-2-yl)-1H-pyrazol-4-amine, C26H36N6
- The crystal structure of poly[2-(4-carboxypyridin-3-yl)terephthalpoly[diaqua-(μ4-2-(6-carboxylatopyridin-3-yl)terephthalato-κ5O,N:O′:O″,O‴)]) cadmium(II)] dihydrate, C28H20Cd3N2O16
- Crystal structure of [tetraaqua-bis((3-carboxy-5-(pyridin-4-yl)benzoate-κ1N)cobalt(II)] tetrahydrate, C26H32CoN2O16
- Crystal structure of bis(μ2-azido-κ2N:N)-tetrakis(azido-κ1N)-tetrakis(1,10-phenanthroline-κ2N,N′)dibismuth(III), C48H32N26Bi2
- Crystal structure of (Z)-N-(4-(4-(4-((4,5,6-trimethoxy-3-oxobenzofuran-2(3H)-ylidene)methyl)phenoxy)butoxy)phenyl)acetamide, C30H31NO8
- Crystal structure of poly[diaqua-(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)-bis(μ2-5-carboxybenzene-1,3-dicarboxylato-O,O′:O″)-aqua-di-zinc dihydrate solvate], C27H28N4O16Zn2
- Crystal structure of 2-(3,5,5-trimethylcyclohex-2-en-1-ylidene)malononitrile, C12H14N2
- Crystal structure of chlorido-(5-nitro-2-phenylpyridine-κ2N,C)-[(methylsulfinyl)methane-κ1S]platinum(II), C13H13ClN2O3PtS
- The crystal structure of the co-crystal 1,4-dioxane–4,6-bis(nitroimino)-1,3,5-triazinan-2-one(2/1), C11H19N7O9
- Crystal structure of [N(E),N′(E)]-N,N′-(1,4-phenylenedimethylidyne)bis-3,5-dimethyl-1H-pyrazol-4-amine di-methanol solvate, C18H20N6·2(CH3OH)
- Crystal structure of catena-poly[bis(μ2-azido-k2N:N′)-(nitrato-K2N:N′)-bis(1,10-phenanthroline-K2N:N′)samarium(III)], C24H16N11O3Sm
- Crystal structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2H)-one, C23H25BrO6
- Crystal structure of bis(3,5-dimethyl-1H-pyrazol-4-ammonium) tetrafluoroterephthate, 2[C5H10N3][C8F4O4]
- Crystal structure of 2-amino-4-(2-fluoro-4-(trifluoromethyl)phenyl)-9-methoxy-1,4,5,6-tetrahydrobenzo[h]quinazolin-3-ium chloride, C20H18ClF4N3O
- Crystal structure of 6-(pyridin-3-yl)-1,3,5-triazine-2,4-diamine-sebacic acid (2/1), C13H17N6O2